In our previous work we showed that a novel water-soluble and orally bioavailable nanoformulation of rapamycin named Rapatar effectively delayed carcinogenesis and increased lifespan in highly tumor-prone p53–/– mice [32]. This evidence concerns the gene TP53 and neoplasm.